| Chapter 1 Nutrient and Gene Interactions in Cancer |
|
1 | (18) |
|
|
|
|
|
|
1 | (1) |
|
1.2 Types of Epidemiological Studies |
|
|
1 | (2) |
|
|
|
3 | (1) |
|
1.4 Analytic Epidemiology: Case—Control and Prospective Cohort Studies |
|
|
4 | (3) |
|
|
|
7 | (1) |
|
1.6 Randomized Intervention Trials |
|
|
8 | (1) |
|
1.7 The Combined Study of Genetics and Nutrition in Epidemiological Studies |
|
|
9 | (4) |
|
1.8 Public Health Implications of Nutrient—Environment Interactions |
|
|
13 | (1) |
|
1.9 Summary and Conclusion |
|
|
14 | (1) |
|
|
|
15 | (4) |
| Chapter 2 Candidate Mechanisms for Interactions between Nutrients and Genes |
|
19 | (18) |
|
|
|
|
|
|
19 | (1) |
|
2.2 Nutritional Modulation of Gene Expression |
|
|
20 | (3) |
|
2.2.1 Effects on Transcription |
|
|
20 | (2) |
|
2.2.1.1 Cis-Acting Elements |
|
|
20 | (1) |
|
2.2.1.2 Transcription Factors Are Trans-Acting Factors |
|
|
20 | (1) |
|
2.2.1.3 Epigenetic Modifications |
|
|
21 | (1) |
|
2.2.2 Posttranscriptional Control of Gene Expression |
|
|
22 | (1) |
|
2.2.3 Posttranslational Modification |
|
|
23 | (1) |
|
2.3 Impact of Genotype on Responses to Nutrients |
|
|
23 | (2) |
|
2.4 Mechanisms by which Food Constituents May Influence Carcinogenesis |
|
|
25 | (5) |
|
2.4.1 Nutrition, Inflammation, and Cancer Risk |
|
|
26 | (12) |
|
2.4.1.1 Intestinal Bacteria |
|
|
28 | (1) |
|
|
|
29 | (1) |
|
2.5 Nutritional Modulation of DNA Damage and Repair |
|
|
30 | (1) |
|
2.6 Developmental Origins of Cancer |
|
|
31 | (1) |
|
|
|
32 | (1) |
|
|
|
33 | (4) |
| Chapter 3 Biomarkers for Nutrient–Gene Interactions |
|
37 | (20) |
|
Claire E. Robertson and Paolo Vineis |
|
|
|
3.1 Dietetic Modification of Cancer Risk and Relevant Biomarkers |
|
|
38 | (7) |
|
3.1.1 Fruit, Vegetables, and Decreased Cancer Risk: Putative Mechanisms |
|
|
38 | (3) |
|
3.1.1.1 Oxidative DNA Damage (8-OHdG) |
|
|
38 | (2) |
|
3.1.1.2 Bulky DNA Adducts and Mutagen Sensitivity |
|
|
40 | (1) |
|
3.1.2 High Meat Consumption and Increased Risk of Colorectal Cancer |
|
|
41 | (1) |
|
3.1.2.1 Heterocyclic Aromatic Amines (HAA) and HAA Adducts |
|
|
41 | (1) |
|
3.1.2.2 N-Nitroso Compounds |
|
|
42 | (1) |
|
3.1.3 Single Nutrients: Folate |
|
|
42 | (5) |
|
3.1.3.1 Evidence and Strength of Association from Cohort Studies |
|
|
42 | (3) |
|
3.1.3.2 Alcohol and Folate |
|
|
45 | (1) |
|
3.2 Genetic Susceptibility |
|
|
45 | (1) |
|
3.3 Combination of Genes and Pathways |
|
|
46 | (1) |
|
3.4 Fruit, Vegetables, and Decreased Cancer Risk |
|
|
47 | (1) |
|
3.4.1 Hypothesis I: Role of GSTs |
|
|
47 | (1) |
|
3.4.2 Hypothesis II: Repair of Oxidative DNA Damage |
|
|
47 | (1) |
|
3.5 High Meat Consumption and Increased Risk of Colorectal Cancers |
|
|
48 | (1) |
|
|
|
48 | (2) |
|
3.6.1 Folate and MTHFR Polymorphisms |
|
|
48 | (1) |
|
3.6.2 Folate and Promoter Methylation |
|
|
49 | (1) |
|
|
|
50 | (1) |
|
|
|
51 | (1) |
|
|
|
51 | (1) |
|
|
|
51 | (6) |
| Chapter 4 Interaction between Folate and Methylene-tetrahydrofolate Reductase Gene in Cancer |
|
57 | (18) |
|
Sang-Woon Choi and Simonetta Friso |
|
|
|
|
|
57 | (1) |
|
4.2 Folate and the Risk of Colorectal Cancer |
|
|
58 | (2) |
|
4.3 Importance of Folate and MTHFR Gene in One-Carbon Metabolism |
|
|
60 | (2) |
|
4.4 Interaction between Folate and MTHFR Gene |
|
|
62 | (4) |
|
4.4.1 Characteristics of MTHFR Gene Polymorphisms |
|
|
62 | (1) |
|
4.4.2 Mechanism of Folate and MTHFR Gene Interaction |
|
|
63 | (1) |
|
4.4.3 Effect of Folate and MTHFR Gene Interaction on DNA Methylation |
|
|
64 | (2) |
|
4.5 Interaction between Folate and MTHFR Gene in Colorectal Carcinogenesis |
|
|
66 | (1) |
|
4.6 Interaction between Folate and MTHFR Gene in Other Neoplastic Diseases |
|
|
67 | (1) |
|
|
|
67 | (1) |
|
|
|
68 | (1) |
|
|
|
69 | (6) |
| Chapter 5 Genetic Variability in Folate-Mediated One-Carbon Metabolism and Cancer Risk |
|
75 | (18) |
|
|
|
|
|
|
75 | (3) |
|
5.1.1 Investigations of Genetic Variation in Epidemiological Studies |
|
|
77 | (1) |
|
5.2 Genetic Variability in One-Carbon Metabolism |
|
|
78 | (2) |
|
5.2.1 Thymidylate Synthase (TS) |
|
|
78 | (1) |
|
5.2.2 Methionine Synthase (MTR) |
|
|
78 | (1) |
|
5.2.3 Methionine Synthase Reductase (MTRR) |
|
|
79 | (1) |
|
5.2.4 Serine Hydroxymethyltransferase (SHMT) |
|
|
79 | (1) |
|
5.2.5 Cystathionine (3-Synthase (CBS) |
|
|
79 | (1) |
|
5.2.6 Reduced Folate Carrier (RFC) |
|
|
79 | (1) |
|
5.2.7 Other Genes (GGH, DHFR, and TCII) |
|
|
80 | (1) |
|
5.3 Genetic Variability in One-Carbon Metabolism and Cancer Risk |
|
|
80 | (4) |
|
|
|
81 | (2) |
|
5.3.2 Hematopoietic Malignancies |
|
|
83 | (1) |
|
|
|
83 | (1) |
|
|
|
84 | (1) |
|
|
|
84 | (1) |
|
|
|
84 | (9) |
| Chapter 6 S-Adenosylmethionine and Methionine Adenosyltransferase Genes |
|
93 | (20) |
|
José M. Mato, M. Luz Martinez-Chantar, and Shelly C. Lu |
|
|
|
|
|
93 | (1) |
|
6.2 MAT Genes and Their Regulation |
|
|
94 | (3) |
|
6.3 AdoMet Regulation of Hepatocyte Growth |
|
|
97 | (1) |
|
6.4 AdoMet Regulation of Hepatocyte Apoptosis |
|
|
98 | (3) |
|
6.4.1 Differential Effect in Normal vs. Cancerous Hepatocytes |
|
|
98 | (1) |
|
6.4.2 AdoMet-Induced Selective Upregulation of Bcl-xs in HepG2 Cells |
|
|
99 | (2) |
|
6.5 Consequences of Chronic Hepatic AdoMet Deficiency — the MATIA Knockout Mouse Model |
|
|
101 | (4) |
|
6.5.1 Phenotype of the MATIA Null Mice |
|
|
101 | (2) |
|
6.5.2 Genomics of MATIA Knockout Mice |
|
|
103 | (1) |
|
6.5.3 Proteomics of MATIA Knockout Mice |
|
|
104 | (1) |
|
6.5.4 Liver Cancer in MATIA Knockout Mice |
|
|
105 | (1) |
|
6.6 Conclusions and Future Directions |
|
|
105 | (2) |
|
|
|
107 | (1) |
|
|
|
107 | (1) |
|
|
|
108 | (5) |
| Chapter 7 Effects of Carotenoid Supplementation on Signal Transduction Pathways: Significance in Lung Cancer Prevention |
|
113 | (16) |
|
Xiang-Dong Wang and Stacey King |
|
|
|
|
|
113 | (3) |
|
7.2 Effects of Carotenoid Supplementation on Retinoid Signaling Pathway |
|
|
116 | (3) |
|
7.3 Effects of Carotenoid Supplementation on MAPK Pathway |
|
|
119 | (1) |
|
7.4 Effects of Carotenoid Supplementation on IGF-1 Signal Transduction Pathway |
|
|
120 | (3) |
|
|
|
123 | (1) |
|
|
|
124 | (5) |
| Chapter 8 The Actions of the Vitamin D Receptor in Health and Malignancy; Polymorphic Associations and Gene Regulatory Actions |
|
129 | (48) |
|
Moray J. Campbell and Kay W Colston |
|
|
|
|
|
130 | (3) |
|
|
|
130 | (1) |
|
8.1.2 Common and Complex Etiology of Breast, Prostate, and Colon Cancer |
|
|
130 | (2) |
|
8.1.3 Emerging Roles of Diet in Malignancy |
|
|
132 | (1) |
|
8.2 The Vitamin D Receptor Is a Member of the Nuclear Receptor Superfamily |
|
|
133 | (3) |
|
8.2.1 Nuclear Receptors Allow a Local Response to Lipophilic Nutrients |
|
|
133 | (2) |
|
8.2.2 Local Remodeling of Chromatin Is Central to Nuclear Receptor Transcriptional Functions |
|
|
135 | (1) |
|
8.2.3 Other Functions of VDR That Contribute to Cell Regulatory Actions |
|
|
136 | (1) |
|
8.3 The Vitamin D Receptor |
|
|
136 | (3) |
|
8.3.1 The VDR: Expressed in a Broad Panel of Noncalcemic Tissues |
|
|
136 | (1) |
|
8.3.2 Autocrine vs. Paracrine Signaling |
|
|
137 | (1) |
|
8.3.3 VDR Actions in Normal Tissues |
|
|
138 | (1) |
|
8.4 Transcriptional and Cellular Effects of the VDR |
|
|
139 | (4) |
|
8.4.1 Cell Cycle Progression |
|
|
140 | (1) |
|
8.4.2 Programmed Cell Death |
|
|
140 | (1) |
|
8.4.3 Adhesion and Migration |
|
|
141 | (1) |
|
8.4.4 Genomic Integrity and DNA Repair |
|
|
142 | (1) |
|
8.4.5 Integrated Signaling |
|
|
142 | (1) |
|
8.5 In Vivo Actions of the VDR in Tumor Models |
|
|
143 | (3) |
|
8.5.1 VDR Knockout Tumor Models |
|
|
143 | (1) |
|
8.5.2 Other Tumor Models for VDR Actions |
|
|
144 | (2) |
|
8.6 Mechanisms of Suppression and Resistance to the Actions of the VDR |
|
|
146 | (8) |
|
8.6.1 Reduced Environmental Availability of 1alpha;,25(OH)2D3 |
|
|
146 | (2) |
|
8.6.2 Cellular Resistance to the Actions of the VDR |
|
|
148 | (1) |
|
|
|
148 | (4) |
|
8.6.4 Epigenetic Resistance |
|
|
152 | (2) |
|
|
|
154 | (1) |
|
|
|
154 | (23) |
| Chapter 9 The Role of Alcohol Dehydrogenase Polymorphism in Alcohol-Associated Carcinogenesis |
|
177 | (12) |
|
Helmut K. Seitz and Felix Stickel |
|
|
|
|
|
177 | (1) |
|
9.2 Acetaldehyde — a Carcinogen |
|
|
178 | (2) |
|
9.3 ALDH2 Mutation and Its Role in Alcohol-Associated Carcinogenesis |
|
|
180 | (1) |
|
9.4 Polymorphism of Alcohol Dehydrogenase and Its Possible Role in Alcohol-Associated Carcinogenesis |
|
|
181 | (3) |
|
9.4.1 Gastrointestinal Cancer |
|
|
181 | (2) |
|
|
|
183 | (1) |
|
9.5 Summary and Conclusion |
|
|
184 | (1) |
|
|
|
184 | (5) |
| Chapter 10 Genetic Polymorphism of N-Acetyltransferase Genes as Risk Modifiers of Colorectal Cancer from Consumption of Well-Done Meat |
|
189 | (24) |
|
La Creis Renee Kidd, Robert C.G. Martin, Jason H. Moore, and David W Hein |
|
|
|
|
|
190 | (1) |
|
|
|
190 | (1) |
|
10.3 Metabolism of Heterocyclic Amines |
|
|
191 | (1) |
|
10.4 Functional Consequences of Variant Metabolic Activation Genes |
|
|
191 | (1) |
|
|
|
192 | (1) |
|
10.6 N-Acetyltransferase 1 (NAT1) |
|
|
192 | (1) |
|
10.7 N-Acetyltransferase 2 (NAT2) |
|
|
192 | (2) |
|
10.8 Variant CYP1A2 and N-Acetyltransferase Genes and Their Effect on Colorectal Cancer Risk in Rodents and Humans |
|
|
194 | (9) |
|
10.9 CYP1A2 and N-Acetyltransferase Gene Polymorphisms, Alone or in Combination, and Their Effect on Colorectal Cancer Risk among Consumers of Well-Done Meat |
|
|
203 | (2) |
|
10.10 Limitations of Gene–Diet Interaction Studies |
|
|
205 | (1) |
|
10.11 Future Directions: Strategies to Overcome Sample Size Limitations of Diet–Gene Interaction Studies |
|
|
206 | (1) |
|
10.12 The Multifactor Dimensionality Reduction (MDR) Method |
|
|
206 | (1) |
|
|
|
207 | (1) |
|
|
|
208 | (5) |
| Chapter 11 Ferritin and Serine Hydroxymethyltransferase |
|
213 | (24) |
|
|
|
|
11.1 Physiological Role and Regulation of Folate-Mediated One-Carbon Metabolism |
|
|
213 | (3) |
|
11.2 Impairments in Folate-Mediated One-Carbon Metabolism |
|
|
216 | (1) |
|
11.3 Serine Hydroxymethyltransferase |
|
|
217 | (4) |
|
11.3.1 Mitochondrial SHMT |
|
|
218 | (1) |
|
|
|
218 | (5) |
|
11.3.2.1 Serine Synthesis for Gluconeogenesis |
|
|
218 | (1) |
|
11.3.2.2 Regulation of Methylene THF Pools |
|
|
218 | (1) |
|
11.3.2.3 cSHMT as a Metabolic Switch |
|
|
219 | (1) |
|
11.3.2.4 Biosynthesis of 5-Formyl THF |
|
|
220 | (1) |
|
11.4 Regulation of cSHMT Expression |
|
|
221 | (1) |
|
11.5 Iron–Folate Relationships |
|
|
222 | (1) |
|
|
|
222 | (1) |
|
11.7 Folate–Ferritin Interactions |
|
|
223 | (2) |
|
11.7.1 Regulation of Cellular Folate Accumulation |
|
|
223 | (2) |
|
11.7.2 Regulation of cSHMT Expression by Ferritin |
|
|
225 | (1) |
|
11.8 Folate and Carcinogenesis |
|
|
225 | (2) |
|
11.8.1 Mechanism 1: Alteration of DNA Methylation |
|
|
226 | (1) |
|
11.8.2 Mechanism 2: Increased Mutation Rates |
|
|
226 | (1) |
|
11.9 Future Prospects: HCF and cSHMT Interactions in Cancer Prevention |
|
|
227 | (1) |
|
|
|
228 | (9) |
| Chapter 12 Brassica–Gene Interactions and Cancer Risk |
|
237 | (32) |
|
|
|
|
|
|
238 | (1) |
|
12.2 Nutritional Epidemiology |
|
|
239 | (1) |
|
12.3 Brassica Glucosinolates |
|
|
240 | (5) |
|
|
|
240 | (1) |
|
12.3.2 Breakdown of Glucosinolates |
|
|
241 | (4) |
|
12.4 Phase I Enzymes and Brassica |
|
|
245 | (1) |
|
|
|
245 | (1) |
|
12.4.2 Brassica and Phase I Enzyme Induction |
|
|
245 | (1) |
|
12.5 Phase II Enzymes and Brassica |
|
|
246 | (1) |
|
12.5.1 Phase II Enzyme System |
|
|
246 | (1) |
|
12.5.2 Brassica Phytochemicals and Phase II Enzymes |
|
|
247 | (1) |
|
12.5.3 GST Genetic Polymorphisms |
|
|
247 | (1) |
|
12.6 ITCs as Phase II Enzyme Substrates |
|
|
247 | (1) |
|
12.7 Brassica and Chemical Carcinogenesis |
|
|
248 | (1) |
|
12.8 Brassica Consumption, Phase II Enzymes, and Cancer |
|
|
249 | (9) |
|
12.8.1 Modification of the Brassica and Cancer Association by Phase II Enzyme Genetic Polymorphisms |
|
|
250 | (5) |
|
12.8.1.1 Colon Adenomas or Colon Cancer |
|
|
250 | (4) |
|
12.8.1.2 Head and Neck Cancer |
|
|
254 | (1) |
|
|
|
254 | (1) |
|
12.8.2 Possible Limitations of FFQs |
|
|
255 | (1) |
|
12.8.3 Brassica Intake Estimated by Urinary ITC Levels |
|
|
255 | (1) |
|
12.8.4 Association between Urinary ITC Levels and Cancer by GST Polymorphisms |
|
|
256 | (1) |
|
|
|
256 | (1) |
|
|
|
256 | (1) |
|
12.8.5 Brassica—Gene Interactions: What Conclusions Are Possible at This Time? |
|
|
256 | (2) |
|
12.9 Alternative Mechanisms |
|
|
258 | (1) |
|
12.10 Translating Brassica—Cancer Associations to Cancer Prevention |
|
|
258 | (1) |
|
|
|
259 | (1) |
|
|
|
259 | (10) |
| Chapter 13 Conclusions and Future Perspectives |
|
269 | (4) |
|
Simonetta Friso, Roberto Corrocher, and Sang-Woon Choi |
|
|
| Index |
|
273 | |